Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis

被引:48
|
作者
Blaser, J
Triebel, S
Maasjosthusmann, U
Romisch, J
KrahlMateblowski, U
Freudenberg, W
Fricke, R
Tschesche, H
机构
[1] UNIV BIELEFELD,INST BIOCHEM,D-33615 BIELEFELD,GERMANY
[2] ST JOSEFS STIFT SENDENHORST,KLIN RHEUMATOL,BIELEFELD,GERMANY
[3] BEHRINGWERKE AG,RES LABS,W-3550 MARBURG,GERMANY
关键词
metalloproteinases; urokinase-plasminogen-activator; rheumatoid arthritis; synoviorthesis;
D O I
10.1016/0009-8981(95)06172-X
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The concentrations of matrix metalloproteinase-l (MMP-1), matrix metalloproteinase-8 (MMP-8), matrix metalloproteinase-9 (MMP-8), lactoferrin and urokinase plasminogen activator (uPA), tissue-type plasminogen activator (tPA) and the inhibitors, tissue inhibitor of metalloproteinase-l (TIMP-1), plasminogen activator inhibitor-1 (PAI-1), plasminogen activator inhibitor (PAI-2), and alpha(2)-macroglobulin in the synovial fluids of patients with rheumatoid arthritis was determined before and during chemical synoviorthesis with a sodium salt of the fatty acids from cod-liver oil (Varicocid). synovial fluids were obtained before treatment from 37 patients with rheumatoid arthritis and, in most cases, at 8 and 24 h after injection of the agent. Well-established ELISAs were used to determine the amounts of all proteins. All patients with rheumatoid arthritis revealed very high levels of metalloproteinases (about 1-15 mu g/ml) in their synovial fluids. During the inflammation inducing treatment the granulocyte enzymes increased. In contrast to this, the level of MMP-1 decreased. All granulocyte-derived enzymes were strongly correlated with each other, whereas their dependence on the granulocyte count was only weak. uPA and PAI-2 showed good correlations with the granulocytes-derived enzymes, but were also only weakly correlating with the cell counts. tPA was not detected by the ELISA used. The proteases, MMP-8, MMP9 and uPA were increased 8 h after the treatment, whereas the specific inhibitors TIMP-1, PAI-1 and PAI-2 showed significant changes only 24 h after the injection. Matrix metalloproteinases are important factors in the pathogenesis of rheumatoid arthritis. The inflammatory activity in the joint could be better correlated to the granulocyte enzymes than to the granulocyte counts. The levels of uPA and PA1-2 are also parallel to the granulocyte enzyme levels and might underly the same regulatory mechanism.
引用
收藏
页码:17 / 33
页数:17
相关论文
共 50 条
  • [1] Plasminogen activators and their inhibitors in synovial fluids from normal, osteoarthritis, and rheumatoid arthritis knees
    Belcher, C
    Fawthrop, F
    Bunning, R
    Doherty, M
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1996, 55 (04) : 230 - 236
  • [2] Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis
    Yoshihara, Y
    Nakamura, H
    Obata, K
    Yamada, H
    Hayakawa, T
    Fujikawa, K
    Okada, Y
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 (06) : 455 - 461
  • [3] Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and glycosaminoglycans in synovial fluid from patients with rheumatoid arthritis
    Ishiguro, N
    Ito, T
    Miyazaki, K
    Iwata, H
    [J]. JOURNAL OF RHEUMATOLOGY, 1999, 26 (01) : 34 - 40
  • [4] Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis
    Ishiguro, N
    Ito, T
    Oguchi, T
    Kojima, T
    Iwata, H
    Ionescu, M
    Poole, AR
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (11): : 2503 - 2511
  • [5] PLASMINOGEN ACTIVATORS IN SYNOVIAL-FLUID AND PLASMA FROM PATIENTS WITH ARTHRITIS
    BROMMER, EJP
    DOOIJEWAARD, G
    DIJKMANS, BAC
    BREEDVELD, FC
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1992, 51 (08) : 965 - 968
  • [6] PLASMINOGEN ACTIVATORS IN SYNOVIAL-FLUID AND PLASMA FROM PATIENTS WITH ARTHRITIS
    BROMMER, EJP
    DOOYEWAARD, G
    DIJKMANS, BAC
    BREEDVELD, FC
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S337 - S337
  • [7] Presence of cyclophilin a in synovial fluids of patients with rheumatoid arthritis
    Billich, A
    Winkler, G
    Aschauer, H
    Rot, A
    Peichl, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (05): : 975 - 980
  • [8] Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis
    Kanyama, M
    Kuboki, T
    Kojima, S
    Fujisawa, T
    Hattori, T
    Takigawa, M
    Yamashita, A
    [J]. JOURNAL OF OROFACIAL PAIN, 2000, 14 (01): : 20 - 30
  • [9] Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis
    Fiedorczyk, Malgorzata
    Klimiuk, Piotr Adrian
    Sierakowski, Stanislaw
    Gindzienska-Sieskiewicz, Ewa
    Chwiecko, Justyna
    [J]. JOURNAL OF RHEUMATOLOGY, 2006, 33 (08) : 1523 - 1529
  • [10] Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis
    Fiedorczyk, M.
    Klimiuk, P. A.
    Sierakowski, S.
    Gindzienska-Sieskiewicz, E.
    Chwiecko, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 168 - 169